Inhibition of cholesterol absorption with CP-148,623 lowers serum cholesterol in humans

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 3, 1997, Pages 385-389

  Harris, William S ^a   Windsor, Sheryl L ^b   Newton, Fran A ^b   Gelfand, Robert A ^b  

^a ST LUKE S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; CP 148623; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; FECES; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL ABSORPTION; LIPIDS; MALE; SAPONINS; TREATMENT OUTCOME;

EID: 0030937337     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90171-5     Document Type: Article

References (28)

1. Ginsberg HN, Karmally W, Siddiqui M, Halleran S, Tail AR, Blaner WS, et al. Increases in dietary cholesterol are associated with modest increases in both LDL and HDL cholesterol in healthy young women. Arterioscler Thromb Vase Biol 1995;15:169-78.
2. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Rumsey SC, et al. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb 1994;14:576-86.
3. Hopkins PN. Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review. Am J Clin Nutr 1992;55:1060-70.
4. Keys A. Serum cholesterol response to dietary cholesterol. Am J Clin Nutr 1984;40:351-9.
5. Schonfeld G, Patsch W, Rudel LL, Nelson C, Epstein M, Olson RE. Effect of dietary cholesterol and fatty acids on plasma lipoproteins. J Clin Invest 1982;69: 1072-80.
6. Harris WS, Dujovne CA, von Bergmann K, Neal J, Akester J, Windsor SL, et al. Effects of the ACAT inhibitor CL 277,082 on cholesterol metabolism in humans. Clin Pharmacol Ther 1990;48:189-94.
7. Gylling H, Miettinen TA. The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. Atherosclerosis 1995;117:305-8.
8. Himber J, Missano B, Rudling M, Hennes U, Kempen HJ. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets. J Lipid Res 1995;36:1567-85.
9. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995;333:1308-12.
10. Hainer JW, Terry JG, Connell JM, Zyruk H, Jenkins RM, Shand DL, et al. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor DuP 128 on cholesterol absorption and serum cholesterol in humans. Clin Pharmacol Ther 1994;56:65-74.
11. Malinow MR. Effects of synthetic glycosides on cholesterol absorption. Ann NY Acad Sci 1985;454:23-7.
12. Malinow MR. Effects of α- and β-tigogenin cellobiosides on cholesterol absorption. Steroids 1986;48:197-211.
13. Harwood HJ Jr, Chandler CE, Pellarin LD, Bangerter FW, Wilkins RW, Long CA, et al. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin β-tigogenin cellobioside (CP-88818; tiqueside). J Lipid Res 1993;34:377-95.
14. Bangerter FW, Zaccaro LM, Wilkins RW, Wood HA, Wilder DW, Sugarman ED, et al. Animal pharmacology of CP-148,623, a cholesterol absorption inhibitor [abstract]. Atherosclerosis 1994;109:309.
15. Bangerter FW, Wilkins RW, Zaccaro LM, McCarthy PA, DeNinno MP, Morehouse LA, et al. CP-148,623 inhibits cholesterol absorption by preventing cholesterol entry into intestinal mucosa [abstract]. Atherosclerosis 1994;109:310.
16. Crouse JR, Grundy SM. Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man. J Lipid Res 1978;19:967-71.
17. Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption: comparison of sitosterol and sitostanol. Eur J Clin Pharmacol 1991; 40:859-63.
18. Grundy SM, Ahrens EH Jr, Salen G. Dietary betasitosterol as an internal standard to correct for cholesterol losses in sterol balance studies. J Lipid Res 1968;9:374-87.
19. Harris WS, Muzio F. Fish oil reduces postprandial triglyceride concentrations without accelerating lipid emulsion removal rates. Am J Clin Nutr 1993;58:68-74.
20. Bachorik PS, Albers JJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol 1986;129:78-100.
21. Harris WS, Held SJ, Dujovne CA. Comparison of two scoring systems used to monitor diets in outpatient clinical trials. J Cardiovasc Risk 1995;2:359-65.
22. McCarthy PA, DeNinno MP, Morehouse LA, Chandler CE, Bangerter FW, Wilson TC, et al. 11-Ketotigogenin cellobioside (pamaqueside): a potent cholesterol absorption inhibitor in the hamster. J Med Chem 1996;39:100-2.
23. McCarthy PA, DeNinno MP, Morehouse LA, Chandler CE, Beyer TA, Bangerter FW, et al. The discovery of CP-148,623, a potent cholesterol absorption inhibitor in hamsters [abstract]. Atherosclerosis 1994;109: 309.
24. Lees AM, Mok HYI, Lees RS, McCluskey MA, Grundy SM. Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 1977;28:325-38.
25. Kesaniemi YA, Grundy SM. Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. Arteriosclerosis 1984;4:41-8.
26. Kesaniemi YA, Miettinen TA. Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole. Eur J Clin Pharmacol 1991; 40:S65-7.
27. Mattson FH, Erickson BA, Klingman AM. Effect of dietary cholesterol on serum cholesterol in man. Am J Clin Nutr 1972;25:589-94.
28. Chenoweth W, Ullman M, Simpson R, Leveille G. Influence of dietary cholesterol and fat on serum lipids in men. J Nutr 1981;111:2069-80.